Michael Schuster
Corporate Officer/Principal at MESOBLAST LIMITED
Profile
Michael Schuster was the founder of Mesoblast, Inc. (founded in 2001) where he held the title of Head-Business Development from 2001 to 2009.
He is also the founder of Mesoblast Ltd.
where he currently holds the title of Head-Pharma Partnering since 2004.
Additionally, Mr. Schuster has worked as the Head-Investor Relations at Angioblast Systems, Inc. Mr. Schuster's education includes an MBA from Fordham University, an undergraduate degree from Tufts University (conferred in 1999), and a graduate degree from New York Medical College.
Michael Schuster active positions
Companies | Position | Start |
---|---|---|
MESOBLAST LIMITED | Corporate Officer/Principal | 2003-12-31 |
Former positions of Michael Schuster
Companies | Position | End |
---|---|---|
Angioblast Systems, Inc. | Investor Relations Contact | - |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Founder | - |
Training of Michael Schuster
Tufts University | Undergraduate Degree |
New York Medical College | Graduate Degree |
Fordham University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MESOBLAST LIMITED | Health Technology |
Private companies | 2 |
---|---|
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
Angioblast Systems, Inc. |
- Stock Market
- Insiders
- Michael Schuster